New Launch: Liposomal Berberine Hydrochloride LIPOBER in New Dosage Form
New Specification Launched: Liposomal Berberine LIPOBER
Hangzhou Zhaoxu Biotechnology Co., Ltd. has officially launched the Liposome Berberine Hydrochloride (LIPOBER) 40% product. Using liposomal encapsulation technology, this formulation preserves berberine's active properties while offering greater flexibility for formula development.
Berberine, a plant-derived ingredient, has long been a focus in formulation R&D. The application of liposomal technology represents another innovation by Chaoxu Bio in dosage form development.
Samples are now available for this specification. Please request technical data via an inquiry on our website or by emailing info@eastsunbio.com.
English Version
Hangzhou Eastsun Biological Technology Co., Ltd. officially launches Liposomal Berberine Hydrochloride (LIPOBER) 40%. The product uses liposome encapsulation technology to preserve berberine's active ingredients while enabling greater flexibility in formula development.
As a botanical ingredient, berberine has long drawn attention in formula R&D. The use of liposome technology represents another innovation in dosage forms by Eastsun Bio.
Samples of this specification are now available. Please request technical documentation via our website or by emailing info@eastsunbio.com.